Literature DB >> 26051510

Adherence to cancer prevention recommendations and antioxidant and inflammatory status in premenopausal women.

Yukiko Morimoto1, Fanchon Beckford1, Robert V Cooney2, Adrian A Franke1, Gertraud Maskarinec1.   

Abstract

For cancer prevention, the World Cancer Research Fund and American Institute for Cancer Research (WCRF/AICR) emphasise recommendations to improve individual behaviour, including avoidance of tobacco products, maintaining a lean body mass, participating in physical activity, consuming a plant-based diet, and minimising the consumption of energy-dense foods, such as sodas, red and processed meats and alcohol. In the present study of 275 healthy premenopausal women, we explored the association of adherence scores with levels of three biomarkers of antioxidant and inflammation status: serum C-reactive protein (CRP), serum γ-tocopherol and urinary F2-isoprostane. The statistical analysis applied linear regression across categories of adherence to WCRF/AICR recommendations. Overall, seventy-two women were classified as low ( ≤ 4), 150 as moderate (5-6), and fifty-three as high adherers ( ≥ 7). The unadjusted means for CRP were 2.7, 2.0 and 1.7 mg/l for low, moderate and high adherers (P trend= 0.03); this association was strengthened after adjustment for confounders (P trend= 0.006). The respective values for serum γ-tocopherol were 1.97, 1.63 and 1.45 μg/ml (P trend= 0.02 before and P trend= 0.03 after adjustment). Only for urinary F2-isoprostane, the lower values in high adherers (16.0, 14.5, and 13.3 ng/ml) did not reach statistical significance (P trend= 0.18). In an analysis by BMI, overweight and obese women had higher biomarker levels than normal weight women; the trend was significant for CRP (P trend< 0.001) and γ-tocopherol (P trend= 0.003) but not for F2-isoprostane (P trend= 0.14). These findings suggest that both adherence to the WCRF/AICR guidelines and normal BMI status are associated with lower levels of biomarkers that indicate oxidative stress and inflammation.

Entities:  

Keywords:  Cancer prevention; Chronic inflammation; Lifestyle; Nutrition; Recommendations

Mesh:

Substances:

Year:  2015        PMID: 26051510      PMCID: PMC4838598          DOI: 10.1017/S0007114515001658

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  37 in total

1.  Unique nutrition support for research at the Cancer Research Center of Hawaii.

Authors:  Suzanne P Murphy
Journal:  Hawaii Med J       Date:  2002-01

Review 2.  Does gamma-tocopherol play a role in the primary prevention of heart disease and cancer? A review.

Authors:  Marion Dietrich; Maret G Traber; Paul F Jacques; Carroll E Cross; Youqing Hu; Gladys Block
Journal:  J Am Coll Nutr       Date:  2006-08       Impact factor: 3.169

3.  Bioavailability and antioxidant effects of orange juice components in humans.

Authors:  Adrian A Franke; Robert V Cooney; Susanne M Henning; Laurie J Custer
Journal:  J Agric Food Chem       Date:  2005-06-29       Impact factor: 5.279

Review 4.  Methodological aspects about in vitro evaluation of antioxidant properties.

Authors:  Luís M Magalhães; Marcela A Segundo; Salette Reis; José L F C Lima
Journal:  Anal Chim Acta       Date:  2008-02-29       Impact factor: 6.558

5.  Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles.

Authors:  D O Stram; J H Hankin; L R Wilkens; M C Pike; K R Monroe; S Park; B E Henderson; A M Nomura; M E Earle; F S Nagamine; L N Kolonel
Journal:  Am J Epidemiol       Date:  2000-02-15       Impact factor: 4.897

6.  Synthetic carotenoids as internal standards for plasma micronutrient analyses by high-performance liquid chromatography.

Authors:  A A Franke; L J Custer; R V Cooney
Journal:  J Chromatogr       Date:  1993-04-21

7.  Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats.

Authors:  Qing Jiang; Bruce N Ames
Journal:  FASEB J       Date:  2003-05       Impact factor: 5.191

8.  Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol.

Authors:  R V Cooney; A A Franke; P J Harwood; V Hatch-Pigott; L J Custer; L J Mordan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Inflammatory markers in a 2-year soy intervention among premenopausal women.

Authors:  Gertraud Maskarinec; Jana S Steude; Adrian A Franke; Robert V Cooney
Journal:  J Inflamm (Lond)       Date:  2009-04-07       Impact factor: 4.981

10.  Enhancement of intracellular gamma-tocopherol levels in cytokine-stimulated C3H 10T1/2 fibroblasts: relation to NO synthesis, isoprostane formation, and tocopherol oxidation.

Authors:  Yuichiro Tanaka; Leslie A Lesoon Wood; Robert V Cooney
Journal:  BMC Chem Biol       Date:  2007-07-03
View more
  4 in total

1.  Associations between adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and biomarkers of inflammation, hormonal, and insulin response.

Authors:  Fred K Tabung; Teresa T Fung; Jorge E Chavarro; Stephanie A Smith-Warner; Walter C Willett; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2016-11-14       Impact factor: 7.396

2.  Gamma-tocopherol, a major form of vitamin E in diets: Insights into antioxidant and anti-inflammatory effects, mechanisms, and roles in disease management.

Authors:  Qing Jiang; Suji Im; James G Wagner; Michelle L Hernandez; David B Peden
Journal:  Free Radic Biol Med       Date:  2021-12-09       Impact factor: 7.376

3.  Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Recommendations and Breast Cancer in the SUN Project.

Authors:  Rocio Barrios-Rodríguez; Estefanía Toledo; Miguel Angel Martinez-Gonzalez; Inmaculada Aguilera-Buenosvinos; Andrea Romanos-Nanclares; José Juan Jiménez-Moleón
Journal:  Nutrients       Date:  2020-07-13       Impact factor: 5.717

4.  Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and risk of in situ breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Authors:  Nena Karavasiloglou; Anika Hüsing; Giovanna Masala; Carla H van Gils; Renée Turzanski Fortner; Jenny Chang-Claude; Inge Huybrechts; Elisabete Weiderpass; Marc Gunter; Patrick Arveux; Agnès Fournier; Marina Kvaskoff; Anne Tjønneland; Cecilie Kyrø; Christina C Dahm; Helene Tilma Vistisen; Marije F Bakker; Maria-Jose Sánchez; María Dolores Chirlaque López; Carmen Santiuste; Eva Ardanaz; Virginia Menéndez; Antonio Agudo; Antonia Trichopoulou; Anna Karakatsani; Carlo La Vecchia; Eleni Peppa; Domenico Palli; Claudia Agnoli; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Salma Tunå Butt; Signe Borgquist; Guri Skeie; Matthias Schulze; Timothy Key; Kay-Tee Khaw; Kostantinos K Tsilidis; Merete Ellingjord-Dale; Elio Riboli; Rudolf Kaaks; Laure Dossus; Sabine Rohrmann; Tilman Kühn
Journal:  BMC Med       Date:  2019-12-02       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.